Journal Article

Vaccine Administration Decision Making: The Case of Yellow Fever Vaccine

Beth A. Lown, Lin H. Chen, Mary E. Wilson, Emily Sisson, Mark Gershman, Emad Yanni, Emily S. Jentes, Natasha S. Hochberg, Davidson H. Hamer and Elizabeth D. Barnett

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 55, issue 6, pages 837-843
Published in print September 2012 | ISSN: 1058-4838
Published online June 2012 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1093/cid/cis520
Vaccine Administration Decision Making: The Case of Yellow Fever Vaccine

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Background. Providers must counsel travelers to yellow fever (YF)–endemic areas, although risk estimates of disease and vaccine serious adverse events (SAEs) may be imprecise. The impact of risk information and patients’ requests for participation in vaccine decisions on providers’ recommendations is unknown.

Methods. Vaccine providers were surveyed regarding decisions for 4 patient scenarios before and after being presented information about risk of YF disease vs vaccine SAEs. Participants’ theoretical attitudes were compared with actual responses to scenarios in which patients wanted to...

Journal Article.  4318 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.